Research and MAB News
Finding it early saves lives and money. New research out in Current Oncology, Capturing the True Cost of Breast Cancer Treatment: Molecular Subtype and Stage-Specific per-Case Activity-Based Costing details that “…the cost of BC treatment is many orders of magnitude less when BC is diagnosed at an earlier stage, and that costs increase exponentially with stage. The magnitude of difference in cost for treatment of late-stage compared to early-stage BC has been previously noted to be 3–4 times; however, our study shows a cost differential of up to 36 times in magnitude when DCIS is compared with stage IV.”
DBI welcomes new Medical Advisory Board members Dr. Sheila Appavoo and Dr. Lars Grimm and welcomes back Dr. Jennifer Harvey! Our hardworking volunteer MAB members contribute to and review all website content.